Malik Shahzad
Director at Versartis, Inc.; Director at AGEN; Director, 10% owner at Conatus Pharmaceuticals Inc
- Sold, on record
- $19.8M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 17, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Versartis, Inc.Director
- AGENAGENUS INCDirector
- Conatus Pharmaceuticals IncDirector, 10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- AGEN1.1M shares
- Versartis, Inc.650,000 shares
- Conatus Pharmaceuticals Inc535 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Conatus Pharmaceuticals IncPlan not statedJul 30, 2013 2013
Sold 535 shares at $11.00 ($6k)
Malik Shahzad, Director, 10% owner
Sold 0% of holdings ($21.5M position)2M shares leftFirst sale on recordFiling
- 2 Form 4 sale AGENUnusualApr 29, 2015 +638 days
Sold 1.1M shares at $7.11 ($7.9M)
Malik Shahzad, Director
Sold 100% of holdings ($7.9M position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale Versartis, Inc.Plan not statedMar 15, 2017 +686 days
Sold 166,330 shares at $19.09 ($3.2M)
Malik Shahzad, Director
Sold 7.3% of holdings ($43.4M position)2.1M shares leftFirst sale on recordFiling
- 4 Form 4 sale Versartis, Inc.Plan not statedMar 17, 2017 +2 days
Sold 483,670 shares at $18.11 ($8.8M)
Malik Shahzad, Director
Sold 23% of holdings ($38.1M position)1.6M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2017 | Mar 17, 2017 | Versartis, Inc. | Director | Form 4 sale | 483,670 | $8.8M | 23.0% | Plan not stated | SEC |
| Mar 15, 2017 | Mar 15, 2017 | Versartis, Inc. | Director | Form 4 sale | 166,330 | $3.2M | 7.3% | Plan not stated | SEC |
| Apr 29, 2015 | Apr 30, 2015 | AGEN | Director | Form 4 sale | 1.1M | $7.9M | 100.0% | Unusual | SEC |
| Jul 30, 2013 | Aug 1, 2013 | Conatus Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 535 | $6k | 0.0% | Plan not stated | SEC |